The Lancet

Bharat Biotech’s Covaxin Phase 3 Trial Paper Published, Finally

Mix-and-Match Vaccine Schedule Efficacious Against COVID: Lancet Study

As ICMR Revises COVID Guidelines, India Can Exit the Thrall of Ivermectin, HCQ

‘Jury Still Out’: Scientists Call for Open Debate on Origin of Novel Coronavirus

New Covaxin Study Makes Absence of Phase 3 Data More Conspicuous

The COVID-19 Outbreak Has Been Draining Young India’s Mental Health Capital

What Rebuttals to The Lancet’s Editorial on India Got Wrong